Just days before its initial deadline, U.S. regulators say they need more time to decide whether or not to approve Moderna’s respiratory syncytial virus (RSV) vaccine.
Source link
La Potencia Mas Caliente
Just days before its initial deadline, U.S. regulators say they need more time to decide whether or not to approve Moderna’s respiratory syncytial virus (RSV) vaccine.
Source link